Search research articles
Contact Us
Filters
Showing results (301-310 of 338) with videos related to
Page
of 34
Sort By:
Journal of Medical Genetics
|
April 1, 2025
Clinical utility of genome sequencing in autism: illustrative examples from a genomic research study
Thanuja Selvanayagam, Ny Hoang, Ege Sarikaya, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 25, 2011
Design and synthesis of novel enhanced water soluble hydroxyethyl analogs of combretastatin A-4
Megan Lee, Olivia Brockway, Armaan Dandavati, et al.
RSC Advances
|
May 11, 2022
Defined covalent assembly of protein molecules on graphene using a genetically encoded photochemical reaction handle
Athraa J Zaki, Andrew M Hartley, Samuel C Reddington, et al.
Plos One
|
July 29, 2017
Coughing, sneezing, and aching online: Twitter and the volume of influenza-like illness in a pediatric hospital
David M Hartley, Courtney M Giannini, Stephanie Wilson, et al.
Regulatory Toxicology and Pharmacology : RTP
|
October 18, 2001
IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis
C Sonich-Mullin, R Fielder, J Wiltse, et al.
Endocrine-Related Cancer
|
January 10, 2004
Surgery for midgut carcinoid
R Sutton, H E Doran, E M I Williams, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 16, 2013
Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease
Maria C Carrillo, H Robert Brashear, Veronika Logovinsky, et al.
Chemical Science
|
August 21, 2018
Correction: Functional modulation and directed assembly of an enzyme through designed non-natural post-translation modification
Andrew M Hartley, Athraa J Zaki, Adam R McGarrity, et al.
Chemical Science
|
July 15, 2017
Functional modulation and directed assembly of an enzyme through designed non-natural post-translation modification
Andrew M Hartley, Athraa J Zaki, Adam R McGarrity, et al.
BMC Cancer
|
November 23, 2012
Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses
D Alan Anthoney, Jay Naik, Iain R J Macpherson, et al.
Page
of 34
Search research articles
Search
Showing results (301-310 of 338) with videos related to
Sort By:
Page
of 34
Journal of Medical Genetics
|
April 1, 2025
Clinical utility of genome sequencing in autism: illustrative examples from a genomic research study
Thanuja Selvanayagam, Ny Hoang, Ege Sarikaya, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 25, 2011
Design and synthesis of novel enhanced water soluble hydroxyethyl analogs of combretastatin A-4
Megan Lee, Olivia Brockway, Armaan Dandavati, et al.
RSC Advances
|
May 11, 2022
Defined covalent assembly of protein molecules on graphene using a genetically encoded photochemical reaction handle
Athraa J Zaki, Andrew M Hartley, Samuel C Reddington, et al.
Plos One
|
July 29, 2017
Coughing, sneezing, and aching online: Twitter and the volume of influenza-like illness in a pediatric hospital
David M Hartley, Courtney M Giannini, Stephanie Wilson, et al.
Regulatory Toxicology and Pharmacology : RTP
|
October 18, 2001
IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis
C Sonich-Mullin, R Fielder, J Wiltse, et al.
Endocrine-Related Cancer
|
January 10, 2004
Surgery for midgut carcinoid
R Sutton, H E Doran, E M I Williams, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 16, 2013
Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease
Maria C Carrillo, H Robert Brashear, Veronika Logovinsky, et al.
Chemical Science
|
August 21, 2018
Correction: Functional modulation and directed assembly of an enzyme through designed non-natural post-translation modification
Andrew M Hartley, Athraa J Zaki, Adam R McGarrity, et al.
Chemical Science
|
July 15, 2017
Functional modulation and directed assembly of an enzyme through designed non-natural post-translation modification
Andrew M Hartley, Athraa J Zaki, Adam R McGarrity, et al.
BMC Cancer
|
November 23, 2012
Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses
D Alan Anthoney, Jay Naik, Iain R J Macpherson, et al.
Page
of 34